Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS interim rule means tougher penalties for HIPAA violations

This article was originally published in SRA

Executive Summary

The US Department of Health and Human Services has put out for comment an interim final rule that would impose tougher penalties for violating federal provisions designed to prevent the misuse of personal health information1. Under the rule, penalties could be imposed on “covered entities” (ie health plans, healthcare providers or healthcare clearinghouses), including clinical investigators. The rule will take effect on 30 November, with the comment period running until 29 December.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT038596

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel